What GPs Reveal: Qualitative UTI Research

According to the November 11, 2026 PLOS One study, antibiotic-sparing UTI care is not determined by the GP’s prescribing decision alone. The study found that clinical thresholds, patient expectations, trust, time pressure, practice workflows, and communication with pharmacies all shaped treatment decisions.

• The PLOS One study interviewed 15 GPs between June 10 and July 17, 2025, and identified six themes in their accounts of uncomplicated UTI management.
• The participating GPs had a mean age of 46.6 years, 53.3% were female, and their general-practice experience ranged from 5 to 25 years.
• The interviews lasted an average of 44 minutes, with durations ranging from 32 to 54 minutes, and no substantively new relevant content emerged after the 15 interviews.
• The study found that workload, weekends, public holidays, and limited access to reassessment could make delayed or backup prescribing more attractive.
• The study reported that GP views of pharmacy-based UTI care were often limited by incomplete visibility into pharmacy decisions, treatment details, and referral pathways.

The PLOS One research team used 15 virtual, semi-structured interviews with Swiss GPs who regularly managed uncomplicated UTIs in women. The researchers recruited participants from a pool of approximately 500 teaching physicians affiliated with the Institute of Primary Care in Zurich, Switzerland.

According to the study methods, interviews were conducted between June 10 and July 17, 2025, transcribed verbatim, and analyzed thematically using deductive and inductive coding. The researchers developed an initial coding framework from three interviews, refined the framework through discussion, and applied the finalized codebook to the full dataset.

The PLOS One researchers organized the findings into six themes: antibiotic-prescribing thresholds, trust and patient expectations, practical constraints, practice-staff roles, professional autonomy, and pharmacy-based care. The study focused on GP perspectives, so the findings do not directly represent patients, pharmacists, or non-physician medical staff.

The PLOS One findings suggest that implementing antibiotic-sparing UTI care requires analysis of the broader care pathway, not only the final prescription decision. Researchers studying antimicrobial stewardship should examine how patients enter care, how practice staff communicate options, how clinicians manage uncertainty, and how pharmacies exchange information with general practices.

The study’s interviews show why context matters in qualitative healthcare research. One GP described the gap between policy and routine practice by saying, "By now, the antibiotic-sparing approach is actually the approach of choice in our practice... However, it is still often the case that aspiration and reality are very far apart."

The PLOS One study also identified trust as a condition for conservative management. One GP explained, "If I already know her, I feel that the trust is there; she will come back if it does not get better." This quotation illustrates how relationship history can influence perceived safety and prescribing thresholds.

For healthcare researchers, the practical lesson is to preserve both recurring patterns and meaningful variation. A strong analysis should identify common themes while retaining contradictory accounts, such as support for expanded practice-staff roles alongside concern about training, legal responsibility, clinical experience, and physician oversight.

Because the study concerns clinical decision-making, qualitative findings should inform research and implementation design rather than provide individual medical advice. Clinical decisions about UTI treatment require qualified professionals and applicable local guidance.

The November 11, 2026 PLOS One study shows that antibiotic-sparing UTI management is a negotiated process shaped by clinical reasoning, trust, patient expectations, workload, practice-staff roles, and pharmacy relationships. The study’s 15 interviews and six themes demonstrate the value of qualitative research for revealing mechanisms that routine prescribing data cannot fully explain.

AI-enabled qualitative research can help healthcare teams process interview evidence more consistently, compare perspectives across roles, and preserve the quotations and contextual details behind an interpretation. Researchers should use AI as an analytical aid with human review, clear documentation, and appropriate safeguards for sensitive data.

To accelerate transcript analysis while keeping the evidence traceable, try Evidano for free.